Safety and effectiveness of eculizumab in Japanese patients with generalized myasthenia gravis: Analysis of 1‐year postmarketing surveillance
- Resource Type
- Source
- Clinical and Experimental Neuroimmunology. 13:280-289
- Subject
Immunology and Microbiology (miscellaneous) Immunology Neuroscience (miscellaneous) Neurology (clinical) - Language
- ISSN
- 1759-1961